CMB 11.4% 35.0¢ cambium bio limited

"The question now is whether RGS' very weak financial position...

  1. 513 Posts.
    lightbulb Created with Sketch. 154
    "The question now is whether RGS' very weak financial position will force it to grant an exclusive licence to Kyocera for Progenza in Japan at a rock bottom price"

    Just reminded me of the "talking to multiple interested parties" line that was repeatably rolled out. Assuming that should still be the case given the overall better position now that prior.

 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.045(11.4%)
Mkt cap ! $4.175M
Open High Low Value Volume
39.0¢ 39.0¢ 35.0¢ $46 127

Buyers (Bids)

No. Vol. Price($)
1 75 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 1910 1
View Market Depth
Last trade - 13.58pm 09/08/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.